Navigation Links
Zyoptix Diagnostic Workstation

ProductsZyoptix Diagnostic Workstation
Company Bausch & Lomb Storz
Item Zyoptix Diagnostic Workstation
Features 
  • Measures higher order aberrations through the 5th order
  • Analyzes elevation and curvature measurements on both anterior and posterior surfaces of the cornea
  • Capable of detecting and analyzing posterior corneal abnormalities where some corneal anomalies first appear
  • Features dynamic, Windows-based platform designed to integrate continuing advances via upgradable software
  • Customizable quad maps show any combination of measurements in one convenient format
  • Single data input for both devices.
Description Absolute precision demands absolute knowledge. Access it with the Bausch & Lomb Zyoptix Diagnostic Workstation, uniting two trusted technologies: Zywave II Wavefront Aberrometer and Orbscan IIz Anterior Segment Analysis System. Individually they supply critically important data. Together they transform the science of preoperative refractive planning.
Info Bausch & Lomb Storz
Customer Service: (585) 338-6000
Web site: http://www.storz.com/

Related medicine products :

1. Technolas 217z Zyoptix System
2. Near Point Diagnostic Card Set - BC11982
3. Ocular Koeppe Diagnostic
4. Ocular Posner Diagnostic And Surgical Gonioprism
5. Blu-Slit Diagnostic Light
6. Maxi-Lite Diagnostic Penlight
7. EPT-DX Steerable Diagnostic Catheters
8. Inquiry Steerable Diagnostic Catheters
9. A-Focus Steerable Diagnostic Catheters
10. Inquiry Fixed Curve Diagnostic Catheters
11. Inquiry HIS Diagnostic Catheters
Breaking Medicine Technology:Trubion and Facet Biotech Announce Presentation of Positive TRU-016 Data at the 2009 ASH Annual Meeting 2Trubion and Facet Biotech Announce Presentation of Positive TRU-016 Data at the 2009 ASH Annual Meeting 3Trubion and Facet Biotech Announce Presentation of Positive TRU-016 Data at the 2009 ASH Annual Meeting 4Trubion and Facet Biotech Announce Presentation of Positive TRU-016 Data at the 2009 ASH Annual Meeting 5Trubion and Facet Biotech Announce Presentation of Positive TRU-016 Data at the 2009 ASH Annual Meeting 6Octapharma USA Announces FDA Approval of wilate(R) - the First Replacement Therapy Developed Specifically for von Willebrand Disease 2Octapharma USA Announces FDA Approval of wilate(R) - the First Replacement Therapy Developed Specifically for von Willebrand Disease 3Octapharma USA Announces FDA Approval of wilate(R) - the First Replacement Therapy Developed Specifically for von Willebrand Disease 4Octapharma USA Announces FDA Approval of wilate(R) - the First Replacement Therapy Developed Specifically for von Willebrand Disease 5Despite Limited Capital Equipment Purchases In 2009, The Global Powered Surgical Instrument Market Held Its Value At $800 Million 2Despite Limited Capital Equipment Purchases In 2009, The Global Powered Surgical Instrument Market Held Its Value At $800 Million 3ATS Medical Announces FDA Approval for a Landmark Clinical Investigation of the ATS 3f Aortic Bioprosthesis 4905 1ATS Medical Announces FDA Approval for a Landmark Clinical Investigation of the ATS 3f Aortic Bioprosthesis 4905 2ATS Medical Announces FDA Approval for a Landmark Clinical Investigation of the ATS 3f Aortic Bioprosthesis 4905 3Provocative New Fiction Makes for a Fascinating Fast Paced Read 13713 1Provocative New Fiction Makes for a Fascinating Fast Paced Read 13713 2LiveProcess Implements Emergency Management Platform with 51 Florida Hospitals 55482 1LiveProcess Implements Emergency Management Platform with 51 Florida Hospitals 55482 2